APA (7th ed.) Citation

Hong, C., Chan, L., Chen, K., Lee, H., Huang, L., Yang, Y. S. H., . . . Hu, C. (2022). Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson’s Disease: Preclinical and Clinical Studies. Cells (Basel, Switzerland), 11(21), 3468. https://doi.org/10.3390/cells11213468

Chicago Style (17th ed.) Citation

Hong, Chien-Tai, Lung Chan, Kai-Yun Chen, Hsun-Hua Lee, Li-Kai Huang, Yu-Chen S. H. Yang, Yun-Ru Liu, and Chaur-Jong Hu. "Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson’s Disease: Preclinical and Clinical Studies." Cells (Basel, Switzerland) 11, no. 21 (2022): 3468. https://doi.org/10.3390/cells11213468.

MLA (9th ed.) Citation

Hong, Chien-Tai, et al. "Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson’s Disease: Preclinical and Clinical Studies." Cells (Basel, Switzerland), vol. 11, no. 21, 2022, p. 3468, https://doi.org/10.3390/cells11213468.